The intra-lesional injection of IDO1-expressing fibroblasts in IMQ-induced psoriasis-like dermatitis significantly improves the clinical lesional appearance and reduces the infiltration of IL-17 and IL-23 by lymphocytes and DCs, respectively [126]. This evidence concerns the gene IL17A and skin disorder.